cgs 20625 has been researched along with 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one in 1 studies
Studies (cgs 20625) | Trials (cgs 20625) | Recent Studies (post-2010) (cgs 20625) | Studies (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Trials (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Recent Studies (post-2010) (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) |
---|---|---|---|---|---|
9 | 0 | 2 | 184 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, DA | 1 |
1 review(s) available for cgs 20625 and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one
Article | Year |
---|---|
Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Diazepam; Hypnotics and Sedatives; Muscle Relaxants, Central; Pyrazoles; Rats; Receptors, GABA-A | 1987 |